Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Korean Alzheimer's diagnosis technology company seeks investment.

Project region South Korea
Industry Biomedicine
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

Project highlights original MDS technology - all protein conformational diseases
Project description

The Korean company's Alzheimer's diagnosis technology has the original myelodysplastic syndromes ("MDS") technology (polymer detection technology), which is an original technology for early diagnosis of protein conformational diseases. The company has developed products for early and accurate diagnosis of Alzheimer's disease through blood samples. The company's original MDS technology can be used as a platform technology for diagnosis of all protein conformational diseases. Compared with current technology, the company's Blood Amyloid-β Oligomerization detection technology has the advantages of small amount of blood collection, simple method, quantitative detection, no need for expensive analytical instruments, early diagnosis and so on. In the future, based on MDS platform technology, the company's technology can also be used to detect Parkinson's disease. The company now seeks investment.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive